Modeling the temporal succession of phenotypes & environnnental cues

$240,991P50FY2011MHNIH

University Of Chicago, Chicago IL

Investigators

Linked publications & trials

Paper 38205261 Paper 38177845 Paper 36070757 Paper 34671039 Paper 34280189 Paper 32521007 Paper 32511231 Paper 32296164 Paper 32066829 Paper 31784369 Paper 31430271 Paper 30503843 Paper 30456828 Paper 30449672 Paper 30301884 Paper 30135590 Paper 29957506 Paper 29485041 Paper 29024389 Paper 28902521 Paper 28822752 Paper 28783162 Paper 28652360 Paper 28611204 Paper 28400444 Paper 28344757 Paper 28172529 Paper 28039263 Paper 27862943 Paper 27842596 Paper 27725712 Paper 27688402 Paper 27542772 Paper 27532831 Paper 27522000 Paper 27353665 Paper 27115429 Paper 26776202 Paper 26554009 Paper 26357316 Paper 26338771 Paper 26313485 Paper 26258848 Paper 26252133 Paper 26245380 Paper 26219079 Paper 26212459 Paper 26151311 Paper 26019716 Paper 26003923 Paper 25941339 Paper 25926297 Paper 25784053 Paper 25623160 Paper 25568282 Paper 25533804 Paper 25307299 Paper 25270638 Paper 25255227 Paper 25243493 Paper 25158072 Paper 25131546 Paper 25078762 Paper 25052460 Paper 25034947 Paper 24989054 Paper 24988898 Paper 24895436 Paper 24829188 Paper 24799323 Paper 24733456 Paper 24711425 Paper 24699359 Paper 24687183 Paper 24625521 Paper 24577151 Paper 24564913 Paper 24551397 Paper 24478219 Paper 24464852 Paper 24374161 Paper 24323995 Paper 24289793 Paper 24204291 Paper 24185610 Paper 24074861 Paper 23956017 Paper 23917401 Paper 23710681 Paper 23673339 Paper 23531283 Paper 23239965 Paper 22730434 Paper 22511918 Paper 22422992 Paper 20651141 Paper 20349528

Abstract

This project two serves as the bookends of a hypothesis-test-verify cycle to define the shared and distinct components of neurodevelopmental diseases. For the first bookend: In the context of a large healthcare system, we use the processed electronic health records (through Natural Language Processing[unreadable]NLP) to determine the temporal course of multiple health/clinical attributes observed and/or obtained during the course of care delivery. These then are used, in collaboration with Project 4 to define temporal co-morbidity trajectories for each of these diseases and to determine the extent to which there is shared phenomenology particularly in time. For the second bookend: those genomic variants/sequences that are predicted/hypothesized to define subgroups previously characterized by clinical trajectories, or predict conventional biomarkers/clinical findings and/or (most preferably but most challenging) predict differential therapeutic responsiveness.

View original record on NIH RePORTER →